CTA
NVO

Colonial Trust Advisors’s Novo Nordisk NVO Stock Holding History

Colonial Trust Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Sell
4,067
-699
-15% -$33.1K 0.01% 226
2025
Q4 		$243K Sell
4,766
-456
-9% -$23.3K 0.02% 189
2025
Q3 		$290K Buy
5,222
+1,935
+59% +$113K 0.02% 178
2025
Q2 		$227K Sell
3,287
-228
-6% -$15.5K 0.02% 191
2025
Q1 		$244K Buy
3,515
+2,965
+539% +$245K 0.02% 187
2024
Q4 		$47.3K Hold
550
– – ﹤0.01% 315
2024
Q3 		$65.5K Hold
550
– – 0.01% 304
2024
Q2 		$78.5K Buy
550
+4
+0.7% +$530 0.01% 273
2024
Q1 		$70.1K Buy
546
+96
+21% +$11.4K 0.01% 283
2023
Q4 		$46.6K Hold
450
– – ﹤0.01% 324
2023
Q3 		$40.9K Hold
450
– – ﹤0.01% 346
2023
Q2 		$36.4K Hold
450
– – ﹤0.01% 369
2023
Q1 		$35.8K Hold
450
– – ﹤0.01% 370
2022
Q4 		$30.5K Buy
+450
New +$26.4K ﹤0.01% 387

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Colonial Trust Advisors's NVO Position: Q1 2026 in Review

Colonial Trust Advisors reduced its Novo Nordisk (NVO) stake by 15% in Q1 2026, selling an estimated $33.1K and leaving 4,067 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #226.

Colonial Trust Advisors first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $290K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Colonial Trust Advisors held 4,067 shares of Novo Nordisk worth $149K as of Q1 2026.
  • Colonial Trust Advisors sold 699 Novo Nordisk shares in Q1 2026, an estimated $33.1K.
  • Novo Nordisk made up 0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #226 holding.
  • Colonial Trust Advisors first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
  • Colonial Trust Advisors's Novo Nordisk position peaked at $290K in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.